Trial Profile
A retrospective trial comparing BMD changes between denosumab and bisphosphonates in osteoporotic patients who had completed treatment with teriparatide.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Bisphosphonates (Primary) ; Denosumab (Primary) ; Alendronic acid; Ibandronic acid; Risedronic acid; Teriparatide; Zoledronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases